The European medicines regulator said on Monday it was evaluating an application to use immunosuppressant drug Kineret to treat COVID-19 in adult patients with pneumonia who are at risk of developing severe respiratory failure.
EU considers immunosuppressant to treat COVID patients with pneumonia
